Johannes Vandaele’s Post

View profile for Johannes Vandaele, graphic
Johannes Vandaele

Senior Associate Pharma and Life Sciences at PwC Belgium

Looking for a short read on the challenges of attracting investments, the unique strengths and the importance of sustainability and collaboration in the Belgian biopharma sector? Have a read on this round table discussion where industry leaders and advocates of the biopharmaceutical industry answer key questions and explain their view on the future of biopharma in Belgium. Personally I'm happy to see that patient centricity is becoming more important than ever, although there are also concerns around competitiveness, regulations and attraction of talent. 👉Download our roundtable paper to learn more about these exciting developments in biopharma now https://pwc.to/3UhmnSU 💡This whitepaper is the result of a round table discussion hosted by PwC Belgium with members of the HST group were. The HST Group - Health, Science and Technology Group is an alliance between GSK, Johnson & Johnson, Pfizer and UCB that works closely with other industry players, the government authorities and academia to position Belgium as a global leader in biopharma and healthcare. Together, they discuss challenges around current global and EU developments as well as what other countries and markets are doing to successfully advance in this innovative sector. Their insights and recommendations are invaluable for shaping the future of the Belgian healthcare ecosystem. #PwCBelgium #biopharma #HSTGroup #Healthcare

  • No alternative text description for this image

To view or add a comment, sign in

More Relevant Posts

Johannes Vandaele

481 followers

View Profile

Explore topics